HIV News

A study conducted at the University of California, San Francisco, determined that simply providing antiretroviral medication to homeless or unstably housed men who are HIV positive isn't enough to ensure adherence, and therefore effectiveness, of the drugs.

The use of the combination drug tenofovir-emtricitabine, marketed commercially under the name Truvada, has been shown to be effective when used as a pre-exposure prophylaxis (PrEP) to prevent HIV infection.

Even the most effective prophylaxis in the world won't make a dent in the rates of HIV and other sexually transmitted diseases (STDs) if no one uses them.

Two major factors that contribute to a lack of HIV diagnoses are the embarrassment people feel when going in for testing and a shortage of medical centers in high-risk regions.

In 2009, a study on 16,000 Thai adults that was funded by the National Institutes of Health revealed that an HIV vaccine known as RV144 was partially effective in preventing the transmission of the notoriously hard-to-treat virus.

Many people with HIV take highly active antiretroviral therapy (HAART) in order to curb their risk of passing the virus on to a sexual partner.

HIV has been shown time and again to be a very tricky virus to understand.

Scientists discovered that early treatment with combination antiretroviral therapy (cART) results in a delayed start of long-term HIV treatment.

Researchers at the University of North Carolina, Chapel Hill, recently discovered that the oncology drug vorinostat – which is used to treat lymphoma – forces HIV out of hiding.

As the debate on whether medical marijuana should be legalized continues, researchers are discovering more benefits of this apparently therapeutic herb.

The antiretroviral drug tenofovir has been shown in trials to be somewhat effective at preventing the transmission of HIV through vaginal intercourse.

As with many viruses, HIV is able to mutate itself once in the body in order to evade the immune system.

HIV/AIDS researchers have been issuing recommendations for primary care providers (PCPs) to be on the lookout for patients who may be infected with the viruses.

The Alaska Department of Health and Social Services recently released a bulletin to the public warning of an outbreak of HIV infections.

In honor of National Black HIV/AIDS Awareness Day, Kevin Fenton, M.D., issued a statement.

Today's medicines make it possible for individuals with HIV to live longer and with more quality of life than ever before.

Recently, the U.S. Food and Drug Administration approved the antiretroviral HIV drug raltegravir in individuals aged 2 to 12, some four years after the medication began being used commercially in adults.

Individuals with HIV sometimes experience epilepsy simultaneously, which presents challenges for both the patient and the healthcare provider because the drugs to treat both issues sometimes don't interact well.

Researchers have been working on a microbicide that will help prevent the spread of HIV for years.

The 2011 Breakthrough of the Year.